Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qu & Co was a Dutch quantum-computing algorithms and software company focused on applications in computational chemistry, materials science, optimization, finance, and machine learning rather than a drug-development biotech pipeline. The company developed quantum software and application platforms, including QUBEC for chemistry and materials science use cases, and worked with enterprise customers in sectors including healthcare and pharmaceuticals. Qu & Co collaborated with pharmaceutical companies such as Janssen Pharmaceuticals on quantum methods for pharmaceutical R&D, but it was not itself a therapeutics developer. In January 2022, Qu & Co merged with PASQAL, a neutral-atom quantum computing company, and is best characterized today as an acquired/merged former quantum software company with relevance to life-science R&D tooling rather than a healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qu & Co.